Rigano S, Ferrazzi E, Radaelli T, Cetin E T, Pardi G
Department of Obstetrics and Gynecology, ISBM L. Sacco, Via G. B. Grassi, 74, 20157 Milan, Italy.
Croat Med J. 2000 Sep;41(3):240-4.
To compare sonographic measurements of fetal fat tissue in pregnancies complicated by gestational diabetes (GD), with patients undergoing either a diet only or a combined diet and insulin treatment, to those obtained in pregnancies with a normal glucose challenge test.
Forty-five singleton pregnancies complicated by GD but free of any other maternal disease known to affect fetal growth were recruited. GD was diagnosed by a 3-hour OGTT, and treatment was differentiated according to the glycemic profile. GD mothers were divided into two treatment groups: glycemic profile normalized by diet only treatment (n=16) and by combined diet and insulin treatment (n=29). Fetal biometry and subcutaneous fat tissue thickness of the anterior abdominal wall were sonographically evaluated at the time of diagnosis and every 4 weeks afterwards in both GD and normal glucose challenge test group (n=25).
No differences were found in neonatal outcomes between combined diet and insulin treatment group and normal cases, whereas neonatal weight showed a statistically significant difference between diet only treatment group and healthy population. Abdominal circumference in fetuses from GD mothers and normal fetuses was similar, but there was a difference in the fetal fat tissue thickness at the time of diagnosis.
Increased fetal fat tissue thickness in GD mothers at recruitment and its growth rate reduction during adequate treatment may be a new criterion for direct estimation of fetal metabolic status instead of the traditional indirect evaluation based on maternal glucose concentrations.
比较妊娠期糖尿病(GD)合并妊娠且仅接受饮食治疗或饮食与胰岛素联合治疗的患者与葡萄糖耐量试验正常的妊娠患者胎儿脂肪组织的超声测量结果。
招募了45例单胎妊娠合并GD但无其他已知影响胎儿生长的母体疾病的患者。通过3小时口服葡萄糖耐量试验(OGTT)诊断GD,并根据血糖情况进行治疗区分。GD母亲分为两个治疗组:仅通过饮食治疗使血糖正常化的组(n = 16)和通过饮食与胰岛素联合治疗使血糖正常化的组(n = 29)。在诊断时以及之后每4周对GD组和葡萄糖耐量试验正常组(n = 25)的胎儿进行超声生物测量和前腹壁皮下脂肪组织厚度评估。
饮食与胰岛素联合治疗组与正常病例之间的新生儿结局无差异,而仅饮食治疗组与健康人群之间的新生儿体重存在统计学上的显著差异。GD母亲所生胎儿与正常胎儿的腹围相似,但诊断时胎儿脂肪组织厚度存在差异。
招募时GD母亲胎儿脂肪组织厚度增加及其在充分治疗期间生长速率降低可能是直接评估胎儿代谢状态的新标准,而非基于母体血糖浓度的传统间接评估。